Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales23 00623 92327 88929 94830 98632 739
Operating income (EBITDA)8 0457 0289 63210 42310 86011 224
Operating profit (EBIT)6 5945 7297 7718 4058 7309 284
Pre-Tax Profit (EBT)2 96810 5261 9396 5757 5157 910
Net income2 7568 4229124 1754 9045 016
P/E ratio24,37,9783,120,216,915,7
EPS (GBp )56,717218,880,896,4104
Dividend per Share (GBp )80,080,080,080,080,681,5
Yield5,81%5,83%5,12%4,90%4,94%4,99%
Reference price (GBp )1376137315621632.51632.51632.5
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt14 37710 72713 80413 56512 62212 178
Finance------
Operating income (EBITDA)8 0457 0289 63210 42310 86011 224
Leverage
(Debt/EBITDA)
1,79x1,53x1,43x1,30x1,16x1,09x
Capital Expenditure1 1881 3801 5431 6451 5821 664
Book Value Per Share (BVPS)87,6 PNC106 PNC22,9 PNC53,4 PNC62,7 PNC68,7 PNC
Cash Flow per Share108 PNC53,2 PNC132 PNC143 PNC150 PNC163 PNC
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 80 162 M GBP -
Entreprise Value (EV) 93 727 M GBP 92 785 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 20,2x 16,9x
Capitalization / Revenue 2,68x 2,59x
EV / Revenue 3,13x 2,99x
EV / EBITDA 8,99x 8,54x
Yield (DPS / Price) 4,90% 4,94%
Price to book (Price / BVPS) 30,6x 26,0x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 28,1% 28,2%
operating Leverage (Delta EBIT / Delta Sales) 1,11x 1,12x
Net Margin (Net Profit / Revenue) 13,9% 15,8%
ROA (Net Profit / Asset) 9,32% 10,1%
ROE (Net Profit / Equities) 304% 214%
Rate of Dividend 99,1% 83,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,49% 5,11%
Cash Flow / Sales 23,4% 23,7%
Capital Intensity (Assets / Sales) 1,50x 1,56x
Financial Leverage (Net Debt / EBITDA) 1,30x 1,16x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend